Human CD25/IL-2R alpha (Research Grade Daclizumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Supplier:  R&D Systems MAB9927100

Catalog No. MAB9927-100

Description

CD25/IL-2R alpha Monoclonal specifically detects CD25/IL-2R alpha in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: CD25/IL-2R alpha
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS.
• Host Species: Human
• Purification Method: Protein A or G purified from cell culture supernatant
• Primary or Secondary: Primary
• Test Specificity: Detects human CD25/IL-2 R alpha in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Daclizumab. This product is for research use only.
• Target Species: Human
• Form: Supernatant

• Applications: CyTOF, Flow Cytometry
• Clone: Hu102
• Dilution: Flow Cytometry 0.25μg/10⁶ cells, CyTOF-ready
• Gene Alias: CD25, CD25 antigen, IDDM10, IL-2 R alpha, IL-2 receptor subunit alpha, IL2R, IL2R alpha, IL-2R subunit alpha, IL-2Ra, IL2RA, IL-2-RA, IL2-RA, interleukin 2 receptor, alpha, interleukin-2 receptor subunit alpha, p55, TAC antigen, TCGFR
• Immunogen: Human CD25/IL-2 R alpha
• Quantity: 100 μg
• Gene ID (Entrez): 3559
• Reconstitution: Reconstitute at 0.5mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
• Isotype: IgG1